A U-M-led study in the @ASCO_pubs#JCO found omitting androgen-deprivation therapy from treatment with external-beam radiotherapy plus a brachytherapy boost may be associated with poorer overall survival in higher risk localized prostate cancer.
https://t.co/7p3ZFfdNrD